Brief: Hofseth Biocare Q1 EBITDA Swings To Loss Of NOK 14.9 Million
May 9 (Reuters) - HOFSETH BIOCARE ASA HOFBC.OL :
* Q1 SALES REVENUE NOK 14.8 MILLION VERSUS NOK 6.4 MILLION
YEAR
AGO
* Q1 EBITDA LOSS NOK 14.9 MILLION VERSUS PROFIT NOK 36.7
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE3T2mT
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering